A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors.
Fernández-Pisonero I, Clavaín L, Robles-Valero J, Lorenzo-Martín LF, Caloto R, Nieto B, García-Macías C, Oeste CL, Sánchez-Martín M, Abad A, Hortal A, Caballero D, González M, Dosil M, Alarcón B, Bustelo XR.
Fernández-Pisonero I, et al. Among authors: dosil m.
Cell Rep. 2022 Mar 15;38(11):110522. doi: 10.1016/j.celrep.2022.110522.
Cell Rep. 2022.
PMID: 35294890
Free article.